Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients?

Torquati A, Lutfi R, Abumrad N, Richards WO.

J Gastrointest Surg. 2005 Nov;9(8):1112-6; discussion 1117-8.

PMID:
16269382
2.

Long-term effects of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients.

Dogan K, Betzel B, Homan J, Aarts EO, Ploeger N, de Boer H, Aufenacker TJ, van Laarhoven CJ, Janssen IM, Berends FJ.

Obes Surg. 2014 Nov;24(11):1835-42. doi: 10.1007/s11695-014-1310-2.

PMID:
25027982
3.

Long-term follow-up of the metabolic profiles in obese patients with type 2 diabetes mellitus after Roux-en-Y gastric bypass.

Kim S, Richards WO.

Ann Surg. 2010 Jun;251(6):1049-55. doi: 10.1097/SLA.0b013e3181d9769b.

PMID:
20485144
4.

Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status.

Blackstone R, Bunt JC, Cortés MC, Sugerman HJ.

Surg Obes Relat Dis. 2012 Sep-Oct;8(5):548-55. doi: 10.1016/j.soard.2012.05.005. Epub 2012 May 18.

PMID:
22721581
5.

Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).

Yi B, Jiang J, Zhu L, Li P, Im I, Zhu S.

Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1061-8. doi: 10.1016/j.soard.2014.12.029. Epub 2015 Jan 5.

PMID:
25843397
6.

Preoperative fasting plasma C-peptide level may help to predict diabetes outcome after gastric bypass surgery.

Aarts EO, Janssen J, Janssen IM, Berends FJ, Telting D, de Boer H.

Obes Surg. 2013 Jul;23(7):867-73. doi: 10.1007/s11695-013-0872-8.

PMID:
23475775
7.

Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D.

Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5.

8.

Impact of roux-en Y gastric bypass surgery on prognostic factors of type 2 diabetes mellitus: meta-analysis and systematic review.

Chen Y, Zeng G, Tan J, Tang J, Ma J, Rao B.

Diabetes Metab Res Rev. 2015 Oct;31(7):653-62. doi: 10.1002/dmrr.2622. Epub 2014 Dec 17. Review.

PMID:
25387821
9.

Efficacy of Bariatric Surgery in Type 2 Diabetes Mellitus Remission: the Role of Mini Gastric Bypass/One Anastomosis Gastric Bypass and Sleeve Gastrectomy at 1 Year of Follow-up. A European survey.

Musella M, Apers J, Rheinwalt K, Ribeiro R, Manno E, Greco F, Čierny M, Milone M, Di Stefano C, Guler S, Van Lessen IM, Guerra A, Maglio MN, Bonfanti R, Novotna R, Coretti G, Piazza L.

Obes Surg. 2016 May;26(5):933-40. doi: 10.1007/s11695-015-1865-6.

PMID:
26341086
10.

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.

Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Bantle JP, Ikramuddin S.

Ann Surg. 2012 Feb;255(2):287-93. doi: 10.1097/SLA.0b013e318232b033.

PMID:
21975321
11.

Predictors of Remission of T2DM and Metabolic Effects after Laparoscopic Roux-en-y Gastric Bypass in Obese Indian Diabetics-a 5-Year Study.

Bhasker AG, Remedios C, Batra P, Sood A, Shaikh S, Lakdawala M.

Obes Surg. 2015 Jul;25(7):1191-7. doi: 10.1007/s11695-014-1501-x.

PMID:
25399348
12.

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J.

Ann Surg. 2012 Dec;256(6):1023-9. doi: 10.1097/SLA.0b013e318262ee6b.

PMID:
22968072
13.

Impact of Roux-en-Y gastric bypass on regulation of diabetes type 2 in morbidly obese patients.

Proczko-Markuszewska M, Stefaniak T, Kaska L, Kobiela J, Sledziński Z.

Surg Endosc. 2012 Aug;26(8):2202-7. doi: 10.1007/s00464-012-2160-4. Epub 2012 Feb 21.

14.

Early results of Roux-en-Y gastric by-pass on regulation of diabetes type 2 in patients with BMI above and below 35 kg/m2.

Proczko-Markuszewska M, Stefaniak T, Kaska Ł, Sledziński Z.

Pol Przegl Chir. 2011 Feb;83(2):81-6. doi: 10.2478/v10035-011-0013-9.

PMID:
22166285
15.

Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Park JY, Kim YJ.

Obes Surg. 2016 Apr;26(4):749-56. doi: 10.1007/s11695-015-1823-3.

PMID:
26205218
16.
17.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007. Epub 2009 Feb 26.

PMID:
19460674
18.

Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.

Beleigoli AM, Coelho AL, Diniz MT, Lages Savassi-Rocha A, Diniz Mde F.

Surg Obes Relat Dis. 2014 Nov-Dec;10(6):1022-7. doi: 10.1016/j.soard.2014.08.016. Epub 2014 Sep 6.

PMID:
25445150
19.

Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?

de Gordejuela AG, Pujol Gebelli J, García NV, Alsina EF, Medayo LS, Masdevall Noguera C.

Surg Obes Relat Dis. 2011 Jul-Aug;7(4):506-9. doi: 10.1016/j.soard.2011.01.003. Epub 2011 Jan 28.

PMID:
21411376
20.

Insulin sensitivity is related to glycemic control in type 2 diabetes and diabetes remission after Roux-en Y gastric bypass.

Gavin TP, Ernst JM, Caudill SE, Dohm GL, Pories WJ, Dar M, Reed MA.

Surgery. 2014 Jun;155(6):1036-43. doi: 10.1016/j.surg.2014.02.005. Epub 2014 Feb 8.

PMID:
24856123

Supplemental Content

Support Center